Head-to-head · WeighScore
Oria Meds vs yourEra
The verdict
yourEra takes it — 83.8/100 to 63.6/100.
yourEra grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. A both-molecule compounded program that publishes its prices up front — semaglutide $199/mo, tirzepatide $299/mo — across a 50-state clinician network, with an optional coaching-plus-labs membership and a NAD+/microdosing menu on the side.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | Oria Meds | yourEra |
|---|---|---|
| WeighScore | 63.6/100 | 83.8/100 |
| Grade | C | B |
| Site position | #283 | #8 |
| Semaglutide | $199/mo (first month $89; the three- and six-month plans both cost $209 a month) | $199/mo |
| Tirzepatide | $369/mo (first month $129; three months $316/mo, six months $299/mo) | $299/mo |
| Coverage | All 50 states | All 50 states |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Not confirmed | Not confirmed |
Site position #283 · C
Strengths
- Names its dispensing pharmacy, PerfectRx, with a street address and a phone number
- Free shipping and interest-free installments are offered at checkout
- The intake's plan menu returned identical ladders in two different states, so the price is not being varied by geography in the states tested
- Coverage is stated as all 50 states, subject to provider availability
Where it loses points
- Neither semaglutide nor tirzepatide is named anywhere on the public site; the molecule first appears at step two of the intake, after name, email, phone and shipping address are collected
- The homepage sells “starting at $149” and “starting at $249” and neither figure appears in the intake in either state tested
- The semaglutide ladder is inverted: one month is $199 a month, three months and six months are both $209 a month
- $89 and $129 are first-month promotional rates; the standing rates are $199 and $369
- A second price table sits in the homepage script and renders nowhere, quoting a $329 tirzepatide figure the live intake contradicts
- Two different scarcity counters appear on consecutive checkout screens, and review turnaround is stated as 24 hours in one place and 48 in another
- No legal entity, state of organization or governing law is published, and no clinician or NPI is named
Site position #8 · B
Strengths
- Transparent, publicly listed pricing — many compounded competitors hide price behind a quiz
- Both semaglutide and tirzepatide, not a single-drug menu, plus NAD+ and microdosing lines
- Markets a 50-state licensed-clinician network; no insurance required, HSA/FSA accepted
- Optional yourEra Optimum membership adds 1:1 coaching, a nutritionist, at-home lab draws and wearables
Where it loses points
- Compounded semaglutide/tirzepatide are not FDA-approved (not the same as Wegovy/Ozempic/Zepbound)
- Mid-market pricing ($199 sema / $299 tirz) — above the cheapest compounders
- No brand-name lane and no oral route — weekly injectable only
- Thin independent footprint; the 50-state and efficacy claims are self-reported
Featured provider
yourEra
yourEra scores 83.8/100 (B). A both-molecule compounded program that publishes its prices up front — semaglutide $199/mo, tirzepatide $299/mo — across a 50-state clinician network, with an optional coaching-plus-labs membership and a NAD+/microdosing menu on the side.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.